DK148795C - Anologifremgangsmaade til fremstilling af 3-(2-morpholino-ethyl-amino)-5-phenyl-pyridazin eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents

Anologifremgangsmaade til fremstilling af 3-(2-morpholino-ethyl-amino)-5-phenyl-pyridazin eller farmaceutisk acceptable syreadditionssalte deraf

Info

Publication number
DK148795C
DK148795C DK354482A DK354482A DK148795C DK 148795 C DK148795 C DK 148795C DK 354482 A DK354482 A DK 354482A DK 354482 A DK354482 A DK 354482A DK 148795 C DK148795 C DK 148795C
Authority
DK
Denmark
Prior art keywords
anology
pyridazine
morpholino
phenyl
ethyl
Prior art date
Application number
DK354482A
Other languages
English (en)
Other versions
DK354482A (da
DK148795B (da
Inventor
Jean-Paul Kan
Kathleen Biziere
Camille Georges Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DK354482A publication Critical patent/DK354482A/da
Publication of DK148795B publication Critical patent/DK148795B/da
Application granted granted Critical
Publication of DK148795C publication Critical patent/DK148795C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
DK354482A 1981-08-07 1982-08-06 Anologifremgangsmaade til fremstilling af 3-(2-morpholino-ethyl-amino)-5-phenyl-pyridazin eller farmaceutisk acceptable syreadditionssalte deraf DK148795C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8115380 1981-08-07
FR8115380A FR2510998B1 (fr) 1981-08-07 1981-08-07 Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent

Publications (3)

Publication Number Publication Date
DK354482A DK354482A (da) 1983-02-08
DK148795B DK148795B (da) 1985-09-30
DK148795C true DK148795C (da) 1986-03-10

Family

ID=9261294

Family Applications (2)

Application Number Title Priority Date Filing Date
DK354482A DK148795C (da) 1981-08-07 1982-08-06 Anologifremgangsmaade til fremstilling af 3-(2-morpholino-ethyl-amino)-5-phenyl-pyridazin eller farmaceutisk acceptable syreadditionssalte deraf
DK354382A DK148537C (da) 1981-08-07 1982-08-06 Analogifremgangsmaade til fremstilling af 3-aminopyridazinforbindelser eller farmaceutisk acceptable salte deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK354382A DK148537C (da) 1981-08-07 1982-08-06 Analogifremgangsmaade til fremstilling af 3-aminopyridazinforbindelser eller farmaceutisk acceptable salte deraf

Country Status (30)

Country Link
US (1) US4508720A (da)
EP (2) EP0074863B1 (da)
JP (2) JPS5877867A (da)
KR (2) KR880001624B1 (da)
AR (2) AR231441A1 (da)
AT (2) ATE12227T1 (da)
AU (2) AU548931B2 (da)
CA (2) CA1174240A (da)
CS (2) CS229941B2 (da)
DD (2) DD202549A5 (da)
DE (2) DE3262671D1 (da)
DK (2) DK148795C (da)
EG (2) EG15788A (da)
ES (2) ES8305737A1 (da)
FI (2) FI72968C (da)
FR (1) FR2510998B1 (da)
GR (2) GR76430B (da)
HU (2) HU190028B (da)
IE (2) IE53387B1 (da)
IL (2) IL66408A (da)
MA (2) MA19562A1 (da)
NO (2) NO157102C (da)
NZ (2) NZ201520A (da)
OA (2) OA07176A (da)
PH (1) PH18545A (da)
PL (2) PL137199B1 (da)
PT (2) PT75351B (da)
SU (2) SU1138024A3 (da)
YU (2) YU171882A (da)
ZA (2) ZA825512B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
US4565814A (en) * 1983-01-28 1986-01-21 Sanofi Pyridazine derivatives having a psychotropic action and compositions
US4628088A (en) * 1984-07-17 1986-12-09 Eli Lilly And Company Preparation of substituted pyridazines
EP0190563B1 (de) * 1985-01-14 1989-08-02 Boehringer Ingelheim Kg Neue 12-Amino-pyridazino[4',5':3,4]pyrrolo-[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2665442B1 (fr) * 1990-07-31 1992-12-04 Sanofi Sa Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2642648B1 (fr) * 1989-02-07 1991-06-21 Sanofi Sa Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique
FR2654727B1 (fr) * 1989-11-17 1992-03-27 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
US5461053A (en) * 1989-02-07 1995-10-24 Sanofi Pyridazine derivatives
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
FR2642754B1 (fr) * 1989-02-07 1991-05-24 Sanofi Sa Nouveaux derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant
PT93060B (pt) 1989-02-07 1995-12-29 Sanofi Sa Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
WO2003018563A1 (en) * 2001-08-31 2003-03-06 Northwestern University Anti-inflammatory and protein kinase inhibitor composition and method of use
JP2006507237A (ja) * 2002-08-13 2006-03-02 メルク シャープ エンド ドーム リミテッド Gaba受容体に対するリガンドとしてのフェニルピリダジン誘導体
ATE523199T1 (de) * 2004-11-02 2011-09-15 Univ Northwestern Pyridazinverbindungen und verfahren
AU2005302225B2 (en) * 2004-11-02 2012-05-24 Centre National De La Recherche Scientifique Pyridazine compounds, compositions and methods
EP2015751A2 (en) * 2006-04-28 2009-01-21 Northwestern University Salts of pyridazine compounds
AU2007243280A1 (en) 2006-04-28 2007-11-08 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
CA2650711A1 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
RU2555969C1 (ru) * 2014-07-09 2015-07-10 Юлия Алексеевна Щепочкина Керамическая масса для изготовления облицовочной плитки

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives

Also Published As

Publication number Publication date
ATE12227T1 (de) 1985-04-15
HU189166B (en) 1986-06-30
MA19562A1 (fr) 1983-04-01
FI72969B (fi) 1987-04-30
FI822747L (fi) 1983-02-08
PL237809A1 (en) 1983-02-28
AR231441A1 (es) 1984-11-30
KR890001569B1 (ko) 1989-05-08
IE821779L (en) 1983-02-07
DK148537B (da) 1985-07-29
FI72968B (fi) 1987-04-30
MA19560A1 (fr) 1983-04-01
DK354382A (da) 1983-02-08
DK354482A (da) 1983-02-08
YU171882A (en) 1985-03-20
DK148795B (da) 1985-09-30
DE3269383D1 (en) 1986-04-03
EG15788A (en) 1986-09-30
DK148537C (da) 1986-01-13
EP0074863B1 (fr) 1986-02-26
IL66409A0 (en) 1982-11-30
PT75351A (fr) 1982-08-01
IL66408A (en) 1985-12-31
KR840001145A (ko) 1984-03-28
NO822510L (no) 1983-02-08
ES514794A0 (es) 1983-04-16
CA1179346A (en) 1984-12-11
FI822748L (fi) 1983-02-08
DD202715A5 (de) 1983-09-28
AU8655382A (en) 1983-02-10
NO822509L (no) 1983-02-08
PL237808A1 (en) 1983-02-28
ZA825513B (en) 1983-06-29
JPS5877868A (ja) 1983-05-11
EP0074863A1 (fr) 1983-03-23
US4508720A (en) 1985-04-02
KR880001624B1 (ko) 1988-09-02
IL66409A (en) 1985-09-29
GR76429B (da) 1984-08-10
KR840001159A (ko) 1984-03-28
CS229941B2 (en) 1984-07-16
NZ201520A (en) 1985-04-30
AU8655482A (en) 1983-02-10
YU172082A (en) 1985-03-20
FI822747A0 (fi) 1982-08-06
SU1140685A3 (ru) 1985-02-15
FR2510998A1 (fr) 1983-02-11
EG15747A (en) 1986-06-30
PT75351B (fr) 1984-08-01
IE53387B1 (en) 1988-10-26
JPS5877867A (ja) 1983-05-11
AR231637A1 (es) 1985-01-31
OA07175A (fr) 1984-04-30
FI822748A0 (fi) 1982-08-06
ES8305738A1 (es) 1983-04-16
ES8305737A1 (es) 1983-04-16
EP0072726B1 (fr) 1985-03-20
DE3262671D1 (en) 1985-04-25
FI72969C (fi) 1987-08-10
PT75350B (fr) 1984-08-01
NO157102C (no) 1988-01-20
PT75350A (fr) 1982-08-01
HU190028B (en) 1986-08-28
GR76430B (da) 1984-08-10
AU548931B2 (en) 1986-01-09
FI72968C (fi) 1987-08-10
FR2510998B1 (fr) 1986-01-10
JPH0459312B2 (da) 1992-09-21
NO157102B (no) 1987-10-12
SU1138024A3 (ru) 1985-01-30
ATE18216T1 (de) 1986-03-15
IE821778L (en) 1983-02-07
EP0072726A1 (fr) 1983-02-23
DD202549A5 (de) 1983-09-21
IE53388B1 (en) 1988-10-26
ES514795A0 (es) 1983-04-16
PL137199B1 (en) 1986-05-31
PH18545A (en) 1985-08-09
AU548930B2 (en) 1986-01-09
OA07176A (fr) 1984-04-30
NO157861C (no) 1988-06-01
PL130647B1 (en) 1984-08-31
IL66408A0 (en) 1982-11-30
CS229940B2 (en) 1984-07-16
NO157861B (no) 1988-02-22
ZA825512B (en) 1983-06-29
CA1174240A (en) 1984-09-11
NZ201518A (en) 1985-04-30

Similar Documents

Publication Publication Date Title
DK74282A (da) Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK149895C (da) Fremgangsmaade til fremstilling af alfa-aminoacylprolyl-ng-carboxy-argininaldehydderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK148795C (da) Anologifremgangsmaade til fremstilling af 3-(2-morpholino-ethyl-amino)-5-phenyl-pyridazin eller farmaceutisk acceptable syreadditionssalte deraf
DK462380A (da) Analogifremgangsmaade til fremstilling af 2,4-diaminoquinazolin-forbindelser eller syreadditionssalte deraf
DK151623C (da) Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK149308C (da) Analogifremgangs-maade til fremstilling af trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater eller farmaceutisk acceptablesyreadditionssalte deraf
DK106882A (da) Fremgangsmaade til fremstilling af 3,4-dihydro-5h-2,3-benzodiazepin-derivater eller farmaceutisk acceptable syreadditionssalte deraf
DK157862C (da) Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK413783D0 (da) Fremgangsmade til fremstilling af 20-amino-macrolidderivater eller syreadditionssalte deraf
DK162842C (da) Analogifremgangsmaade til fremstilling af 1-perfluoralkyl-2-(1,2,4-triazol-1-yl)-ethanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK148596C (da) Analogifremgangsmaade til fremstilling af 3-aminosubstituerede pyridaziner eller farmaceutisk acceptable syreadditionssalte deraf
DK321482A (da) Fremgangsmaade til fremstilling af 1-imidazolyl-2-phenyl-8-piperazinylphenoxy-octan-2-ol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK157451C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-6-alkoxybenzyl-5-methylpyridooe2,3-daapyrimidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK540283A (da) Fremgangsmaade til fremstilling af thienyleddikesyreamider eller fysiologisk taalelige syreadditionssalte deraf
DK160498C (da) Analogifremgangsmaade til fremstilling af 3-methyl-flavon-8-carboxylsyreestere eller farmaceutisk acceptable syreadditionssalte deraf
DK150597C (da) Analogifremgangsmaade til fremstilling af 3,4-bis-substituerede 1,2,5-oxadiazol-2-oxider eller farmakologisk acceptable syreadditionssalte deraf
DK15282A (da) Fremgangsmaade til fremstilling af (+)-enantiomere eller (+)(-)-racemiske 4a,9b-trans-hexahydro-1h-pyridoindol-derivater eller farmaceutisk acceptable syreadditionssalte deraf
DK157135C (da) Analogifremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK438482A (da) Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
DK148281C (da) Analogifremgangsmaade til fremstilling af 8a-substituerede 8,8a-desoxy-8,8a-dihydrooleandomycin-forbindelser eller farmaceutiskacceptable syreadditionssalte deraf
DK157023C (da) Analogifremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK160875C (da) Analogifremgangsmaade til fremstilling af 3,7-diazabicyklooe3.3.1aa-nonanforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK148903C (da) Analogifremgangsmaade til fremstilling af enkephalin-analoge pentapeptidderivater eller syreadditionssalte deraf
DK152754C (da) Analogifremgangsmaade til fremstilling af 1-acyl-8-(3-amino-2-hydroxypropoxy)-1,2,3,4-tetrahydroquinoliner eller farmaceutisk acceptable syreadditionssalte deraf
DK151021C (da) Analogifremgangsmaade til fremstilling af 17,18-dehydro-apovincaminol-3',4',5'-trimethoxybenzoat eller farmaceutisk acceptable syreadditionssalte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed